NCT02490241View on ClinicalTrials.gov

Lithium Therapy: Understanding Mothers, Metabolism and Mood

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
Bipolar Disorder
Interventions
DRUG

Lithium

Patients taking lithium as a mood stabilizer during pregnancy are eligible to participate in the study. Their dose and serum concentration levels of lithium will be monitored throughout pregnancy and up to three months postpartum.

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02490241 - Lithium Therapy: Understanding Mothers, Metabolism and Mood | Biotech Hunter | Biotech Hunter